查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物晶片市场 - 全球与区域分析 - 分析与预测（2024-2033）
市场调查报告书
商品编码
1397891

生物晶片市场 - 全球与区域分析 - 分析与预测（2024-2033）

Biochips Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2033
出版日期: 按订单生产 | 出版商: BIS Research | 英文 | 商品交期: 7-10个工作天内

价格
简介目录

该报告考察了全球生物晶片市场，并提供了市场概况，包括按技术、最终用户、类型、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

范围和定义

市场/产品定义

关键问题的答案

分析和预测注意事项

第一章市场：产业展望

  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研究发展回顾
  • 监管状况
  • 市场动态概览

第二章 生物晶片市场，依应用分类

  • 应用细分
  • 应用概述
  • 全球生物晶片市场
  • 依技术
  • 按最终用户

第三章生物晶片市场，依类型

  • 产品细分
  • 产品概要
  • 全球生物晶片市场，按类型

第四章生物晶片市场，按地区

  • 区域概况
  • 促进因素和抑制因素
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第五章市场-竞争形势与公司概况

  • 竞争形势
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer Inc.
    • Illumina Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard Bio Tools
    • GE Healthcare
    • Li-COR Inc.
    • Qiagen
    • Randox Laboratories Ltd

第六章 成长机会与建议

第七章调查方法

简介目录
Product Code: BHP1695SA

The global biochip market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecast that a decision maker can take advantage of.

The market study encompasses a detailed examination of various applications including technological advancements, and market dynamics. It explores the market based on segmentations such as by application, by end user, and by product type and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global biobanks market.

Market Segmentation:

Segmentation 1: by Technology

  • Microarrays
  • Microfluidics

Segmentation 2: by End User

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Academic & Research Institutes
  • Others

Segmentation 3: by Type

  • DNA Chips
  • Lab-on-Chip
  • Protein Chips
  • Other Arrays

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Key Questions Answered:

  • What are the major market drivers, challenges and opportunities in the global biochips market and their case studies?
  • How the biochips market evolves and what did is its scope in the future?
  • What is the market share of the leading segments and sub-segments of the global biochips market?
  • How will each segment of the global biochips market grow during the forecast period?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

  • 1.1. Trends: Current and Future Impact Assessment
  • 1.2. Supply Chain Overview
    • 1.2.1. Value chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast
  • 1.3. R&D Review
    • 1.3.1. Patent Filing Trend by Country, by Company
  • 1.4. Regulatory Landscape
  • 1.5. Market Dynamics Overview
    • 1.5.1. Market Drivers
    • 1.5.2. Market Restraints
    • 1.5.3. Market Opportunities

2. Biochip Market by Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Global Biochip Market, by
    • 2.3.1. DNA Chips
      • 2.3.1.1. Gene Expression
      • 2.3.1.2. SNP Genotyping
      • 2.3.1.3. Cancer Diagnosis & Treatment
      • 2.3.1.4. Genomics
      • 2.3.1.5. Drug Discovery
      • 2.3.1.6. Agricultural Biotechnology
      • 2.3.1.7. Other DNA Chip Applications
    • 2.3.2. Lab-on-a-Chip Market
      • 2.3.2.1. Clinical Diagnostics
      • 2.3.2.2. Genomics
      • 2.3.2.3. IVD & POC
      • 2.3.2.4. Proteomics
      • 2.3.2.5. Drug Discovery
      • 2.3.2.6. Others
    • 2.3.3. Protein Chips Market
      • 2.3.3.1. Proteomics
      • 2.3.3.2. Expression Profiling
      • 2.3.3.3. Diagnostics
      • 2.3.3.4. High-Throughput Screening
      • 2.3.3.5. Drug Discovery
    • 2.3.4. Other Arrays
      • 2.3.4.1. Cell Arrays
      • 2.3.4.2. Tissue Arrays
  • 2.4. By Technology
    • 2.4.1. Microarrays
    • 2.4.2. Microfluidics
  • 2.5. By End User
    • 2.5.1. Biotechnology and Pharmaceutical Companies
    • 2.5.2. Hospitals and Diagnostic Centers
    • 2.5.3. Academic & Research Institutes
    • 2.5.4. Others

3. Biochip Market by Product

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Global Biochip Market, by Type
    • 3.3.1. DNA Chips
    • 3.3.2. Lab-on-Chip
    • 3.3.3. Protein Chips
    • 3.3.4. Other Arrays

4. Biochip Market by Region

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Markets
      • 4.3.1.1. Key Market Participants in North America
      • 4.3.1.2. Business Drivers
      • 4.3.1.3. Business Challenges
    • 4.3.2. Application
    • 4.3.3. Product
    • 4.3.4. North America by Country
      • 4.3.4.1. U.S.
      • 4.3.4.2. Canada
  • 4.4. Europe
    • 4.4.1. Markets
      • 4.4.1.1. Key Market Participants in Europe
      • 4.4.1.2. Business Drivers
      • 4.4.1.3. Business Challenges
    • 4.4.2. Application
    • 4.4.3. Product
    • 4.4.4. Europe by Country
      • 4.4.4.1. U.K.
      • 4.4.4.2. Germany
      • 4.4.4.3. France
      • 4.4.4.4. Italy
      • 4.4.4.5. Spain
      • 4.4.4.6. Rest of Europe
  • 4.5. Asia-Pacific
    • 4.5.1. Markets
      • 4.5.1.1. Key Market Participants in Asia-Pacific
      • 4.5.1.2. Business Drivers
      • 4.5.1.3. Business Challenges
    • 4.5.2. Application
    • 4.5.3. Product
    • 4.5.4. Asia-Pacific by Country
      • 4.5.4.1. China
      • 4.5.4.2. Japan
      • 4.5.4.3. India
      • 4.5.4.4. South Korea
      • 4.5.4.5. Rest of Asia-Pacific
  • 4.6. Latin America
    • 4.6.1. Markets
      • 4.6.1.1. Key Market Participants in Latin America
      • 4.6.1.2. Business Drivers
      • 4.6.1.3. Business Challenges
    • 4.6.2. Application
    • 4.6.3. Product
    • 4.6.4. Latin America by Country
      • 4.6.4.1. Brazil
      • 4.6.4.2. Mexico
      • 4.6.4.3. Rest of Latin America
  • 4.7. Middle East and Africa
    • 4.7.1. Markets
      • 4.7.1.1. Key Market Participants in Middle East and Africa
      • 4.7.1.2. Business Drivers
      • 4.7.1.3. Business Challenges
    • 4.7.2. Application
    • 4.7.3. Product

5. Markets - Competitive Landscape & Company Profiles

  • 5.1. Competitive Landscape
  • 5.2. Company Profiles
    • 5.2.1. Thermo Fisher Scientific, Inc.
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers /End-Users
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Market Share
      • 5.2.1.7. Analyst View
    • 5.2.2. Agilent Technologies, Inc.
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers /End-Users
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Market Share
      • 5.2.2.7. Analyst View
    • 5.2.3. PerkinElmer Inc.
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers /End-Users
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Market Share
      • 5.2.3.7. Analyst View
    • 5.2.4. Illumina Inc.
      • 5.2.4.1. Company Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers /End-Users
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Market Share
      • 5.2.4.7. Analyst View
    • 5.2.5. Bio-Rad Laboratories, Inc.
      • 5.2.5.1. Company Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers /End-Users
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Market Share
      • 5.2.5.7. Analyst View
    • 5.2.6. Standard Bio Tools
      • 5.2.6.1. Company Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers /End-Users
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Market Share
      • 5.2.6.7. Analyst View
    • 5.2.7. GE Healthcare
      • 5.2.7.1. Company Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers /End-Users
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Market Share
      • 5.2.7.7. Analyst View
    • 5.2.8. Li-COR Inc.
      • 5.2.8.1. Company Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers /End-Users
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Market Share
      • 5.2.8.7. Analyst View
    • 5.2.9. Qiagen
      • 5.2.9.1. Company Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers /End-Users
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Market Share
      • 5.2.9.7. Analyst View
    • 5.2.10. Randox Laboratories Ltd
      • 5.2.10.1. Company Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers /End-Users
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Market Share
      • 5.2.10.7. Analyst View

6. Growth Opportunities & Recommendations

7. Research Methodology